Epigenetic treatment in mice improves spinal cord regeneration after injury
New Imperial-led research shows that weekly epigenetic treatment in mice can support spinal cord regeneration after severe injury.
Imperial startup GlioQuell has the power to shut down cancer cells
A new company using research from the Department of Brain Sciences will look for drugs to treat brain cancers and diseases of old age.
New device could accelerate the development of T-cell immunotherapies for cancer
Imperial researchers have invented a device that can rapidly select T-cells that are most effective at attacking cancer cells.
Intermittent fasting may help heal nerve damage
Intermittent fasting changes the gut bacteria activity of mice and increases their ability to recover from nerve damage.
Startup with roots at Imperial unlocks the creativity of bacteria
Microbes that cannot normally be grown in the lab may harbour new antibiotics.
New treatment could boost radiotherapy effectiveness for brain tumour patients
A new treatment could significantly improve the effectiveness of radiotherapy for patients diagnosed with the deadliest form of brain tumour.
3
AI for life sciences research gets boost from the financial markets
A technique to find hidden connections between stocks and shares has been applied to discovering and mapping connections between proteins.
1
Identification of the first covalent ligands of the small GTPase Rab27A
A collaborative effort, led by the Tate group, paves the way for the structure-guided discovery of small molecules against Rab27A
Structure, mechanism, and inhibition of Hedgehog Acyltransferase
Collaborative research helps to elucidate the structure and function of membrane-bound protein implicated in cancer
New cross-disciplinary Collaborations Address Societal Challenges
The Institute for Molecular Science and Engineering (IMSE) has funded new cross-disciplinary research to address societal challenges.
